LexDanaLexDanabeta
Inventor

Raymond Sweet

Inventor
Bryn Mawr, PA, US

Overview

47→
Patents
1992–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 47 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
A61JContainers specially adapted for medical or pharmaceutical purposes4%
C07HSugars4%
Y02ATechnologies for adaptation to climate change3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,954,297Methods of treatment using human anti-IL-23 antibodies202110,689,453Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies202010,576,150Anti-IL-23 antibodies202010,301,392Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies201910,272,152Anti-IL-23 antibodies, compositions, methods and uses201910,030,070Human anti-IL-23 antibodies, compositions, methods and uses20189,932,404Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist20189,783,607'Human anti-IL-23 antibodies, compositions, methods and uses'20179,714,287'Anti-IL-23 antibody compositions'20179,683,046'Nucleic acid molecules encoding anti-CD27 antibodies'20179,631,016'Pen-injector device containing anti-IL-6 antibodies'20179,522,957'Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists'20169,505,837'Anti-IL-23 antibodies'20169,481,731'Toll-like receptor 3 antagonists'20169,353,181'Human anti-IL-23 antibodies, compositions, methods and uses'20169,340,613'Anti-IL-6 antibodies, compositions, methods and uses'20169,255,153'Polynucleotides encoding Toll-Like Receptor 3 antagonists'20169,238,693'Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies'20169,127,058'Anti-IL-23 Antibodies'20159,102,737'Human anti-CD27 antibodies, methods and uses'20159,096,667'Anti-IL-23 antibodies, compositions, methods and uses'20159,062,305'Generation of human de novo pIX phage display libraries'20158,623,362'Anti-IL-6 antibodies'20148,540,986'Toll-like receptor 3 antagonists'20138,519,107'IL-17A antibodies'20138,460,659'Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases'20138,409,567'Toll-like receptor 3 antagonists'2013RE043672'Anti-IL-6 antibodies, compositions, methods and uses'20128,226,611'Anti-IL-6 antibodies, compositions, methods and uses'20128,221,760'Methods of treatment using human anti-IL-23 antibodies'20128,153,583'Toll like receptor 3 antagonists, methods and uses'20128,138,315'Anti-alpha V immunoliposome compositions, methods and uses'20128,114,964'Anti-MCP-1 antibodies, compositions, methods and uses'20128,106,177'Nucleic acids encoding human anti-IL-23 antibodies'20128,067,003'Methods of treating conditions using anti-IL-6 antibodies'20117,993,645'Human anti-IL-23 antibodies, compositions, methods and uses'20117,935,344'Human anti-IL-23 antibodies, compositions, methods and uses'20117,833,755'Anti-IL-6 antibody nucleic acid molecules and methods'20107,790,405'Solution phase biopanning method using engineered decoy proteins'20107,560,112'Anti-il-6 antibodies, compositions, methods and uses'20097,514,539'Epitope directed selection of antibodies to murine tissue factor'20096,232,441'PIGR-1, a member of immunoglobulin gene superfamily'20016,114,515'PIGRL-1, a member of immunoglobulin gene superfamily'20006,046,030'Human LIG-1 homolog (HLIG-1)'20006,020,161'PIGR-1, a member of immunoglobulin gene superfamily'20005,422,274'Internal deletion mutants of soluble T4(CD4)'19955,110,906'Derivatives of soluble T-4'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2001Based in Bala Cynwyd, PA, US· patent location history
2009–2021Based in Bryn Mawr, PA, US· patent location history
2010–2016Patents assigned to WU SHENG-JIUN (11)· patent assignee history
2011–2021Patents assigned to JANSSEN BIOTECH INC (32)· patent assignee history
2012–2016Patents assigned to SWEET RAYMOND (12)· patent assignee history
2012–2016Patents assigned to CUNNINGHAM MARK (9)· patent assignee history
2012–2016Patents assigned to RAUCHENBERGER ROBERT (9)· patent assignee history
2012–2015Based in Radnor, PA, US· patent location history
2013–2017Based in Spring House, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN BIOTECH INC322011–2021
SWEET RAYMONDself122012–2016
WU SHENG-JIUN112010–2016
CUNNINGHAM MARK92012–2016
RAUCHENBERGER ROBERT92012–2016
Locations
LocationPatentsSpan
Bryn Mawr, Pennsylvania, US272009–2021
Spring House, Pennsylvania, US72013–2017
Radnor, Pennsylvania, US72012–2015
Bala Cynwyd, Pennsylvania, US61992–2001